Medicine and Dentistry
Cancer Cell
100%
Prostate Cancer
100%
Histone Deacetylase Inhibitor
100%
Double Stranded DNA
100%
Acetylation
100%
Glutamine
40%
DNA Repair
40%
Cell Killing
40%
Mutagenesis
40%
Etoposide
20%
Heterodimer
20%
Binding Affinity
20%
Deacetylation
20%
Vorinostat
20%
Doxorubicin
20%
Trichostatin A
20%
Histone H2AX
20%
Non-Homologous End Joining
20%
DNA Binding
20%
Site-Directed Mutagenesis
20%
Bleomycin
20%
Lysine
20%
Histone
20%
Keyphrases
DNA Double-strand Breaks
100%
Histone Deacetylase Inhibitor (HDACi)
100%
Prostate Cancer Cells
100%
Acetylation
100%
Ku70
100%
DNA Damage
62%
H2AX
25%
Glutamine
25%
Cell Killing
25%
Mutagenesis
25%
Therapeutic Strategies
12%
Overexpression
12%
Etoposide
12%
Prostate Cancer
12%
Trichostatin A
12%
Doxorubicin
12%
DU145
12%
Site-directed mutagenesis
12%
Suberoylanilide Hydroxamic Acid
12%
Bleomycin
12%
Histone Acetylation
12%
DNA Binding Affinity
12%
Sensitizing Effect
12%
Ku80
12%
MS-275
12%
DNA DSB
12%
Non-homologous End-joining Repair
12%
Lysine Residue
12%
Killing Effect
12%
Histone H2AX Phosphorylation
12%
Docking Analysis
12%
Heterodimer Formation
12%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Histone Deacetylase
100%
Acetylation
100%
Ku70
100%
DNA Repair
22%
Glutamine
22%
Mutagenesis
22%
Cell Killing
22%
Histone
22%
Binding Affinity
11%
Deacetylation
11%
DNA Binding
11%
Site-Directed Mutagenesis
11%
Non-Homologous End Joining
11%
Trichostatin A
11%
Ku80
11%
Lysine
11%
Bleomycin
11%
Doxorubicin
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Double Stranded DNA
100%
Histone Deacetylase Inhibitor
100%
Glutamine
40%
Mutagenesis
40%
Heterodimer
20%
Etoposide
20%
Doxorubicin
20%
Vorinostat
20%
Lysine
20%
Trichostatin A
20%
Histone
20%
Site-Directed Mutagenesis
20%
Histone H2AX
20%
Bleomycin
20%
Immunology and Microbiology
Cancer Cell
100%
Acetylation
100%
DNA Repair
40%
Cell Killing
40%
Mutagenesis
40%
DNA Binding
20%
Binding Affinity
20%
Site Directed Mutagenesis
20%
Deacetylation
20%
DNA End Joining Repair
20%